Compass Pathways
UnverifiedFacts from public sources. Is this your company? Claim your page.BiotechLondon, United Kingdom (U.S. office in New Jersey)
The Lobby built this page from public sources. It isn’t maintained by or affiliated with Compass Pathways. Is this your company? Claim your page (free).
Overview
Compass Pathways is a biotechnology company headquartered in London, UK, with a U.S. office in New Jersey. It is developing COMP360 psilocybin treatment, an investigational therapy for treatment-resistant depression (TRD) and PTSD. The company says its rolling NDA submission for TRD is expected to be completed in Q4 2026 and commercial launch is expected in the first half of 2027. It has generated no product revenue to date.
Hiring snapshot
Hiring by specialty
Open roles
Newest first, from Compass Pathways’s careers page.
- Patient Access Liaison (Washington DC)East Coast7d ago$180k–$200k base
- Patient Access Liaison (St. Louis, MO)St. Louis, Missouri7d ago$180k–$200k base
- Patient Access Liaison (Seattle, WA)Seattle, Washington7d ago$180k–$200k base
- Patient Access Liaison (San Francisco, CA)San Francisco, California7d ago$180k–$200k base
- Patient Access Liaison (San Diego, CA)San Diego, California7d ago$180k–$200k base
- Patient Access Liaison (Raleigh, NC)East Coast7d ago$180k–$200k base
Divisions
Division information is pending company verification.Once Compass Pathways claims its page, you will see each division, who it calls on and how it pays.
Claim your pageMore from Compass Pathways
These sections fill in when Compass Pathways claims and verifies its page.